MEDIROM Healthcare Technologies (NYSE:MRM) Rating Increased to Strong-Buy at ThinkEquity

MEDIROM Healthcare Technologies (NYSE:MRM) was upgraded by investment analysts at ThinkEquity to a “strong-buy” rating in a research report issued on Monday,Zacks.com reports.

MEDIROM Healthcare Technologies Trading Down 1.6 %

Shares of MRM opened at $0.94 on Monday. The stock has a 50 day moving average of $1.41 and a 200-day moving average of $2.64. MEDIROM Healthcare Technologies has a 52 week low of $0.83 and a 52 week high of $8.39.

Institutional Inflows and Outflows

A hedge fund recently bought a new stake in MEDIROM Healthcare Technologies stock. Virtu Financial LLC acquired a new stake in shares of MEDIROM Healthcare Technologies Inc. (NYSE:MRM) in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund acquired 10,942 shares of the company’s stock, valued at approximately $33,000. Virtu Financial LLC owned 0.22% of MEDIROM Healthcare Technologies at the end of the most recent reporting period.

About MEDIROM Healthcare Technologies

MEDIROM Healthcare Technologies Inc provides holistic healthcare services in Japan. It operates in three segments: Relaxation Salon, Digital Preventative Healthcare, and Luxury Beauty. The Relaxation Salon segment owns and franchises relaxation salons, which provide finger-pressure style bodywork therapy, stretch therapy, and posture and joint alignment, as well as physical therapy elements; and various individual services, including anti-fatigue therapy, athletic support therapy, slim-down therapy, and reflexology.